Feasibility Study For Utilities And Ventilation Risk - Clinical Trial…

  Address - Canada

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 98740303

  Document Type - Tender Notices

Description - Description: Feasibility Study for Utilities and Ventilation Risk Mitigation Services for a new Clinical Trial Manufacturing Facility .The National Research Council of Canada is building a new Clinical Trial Manufacturing Facility (CTMF) that will ho use the process and equipment for the production and the quality control of protein, viral vector or virus-like particle vaccines or biologics. The products are mainly intended for the Canadian market, regulated by Health Canada under the authority of the Food and Drugs Act. The facility will require being compliant with Canadian Good Manufacturing Practices (GMP) as well as FDA current GMP (cGMP) and Eudralex requirements. The new manufacturing

Gt Ref Id - 98740303

Deadline - Dec 23, 2024